Edition:
United Kingdom

Menlo Therapeutics Inc (MNLO.OQ)

MNLO.OQ on NASDAQ Stock Exchange Global Select Market

5.65USD
19 Oct 2018
Change (% chg)

$-0.37 (-6.15%)
Prev Close
$6.02
Open
$6.02
Day's High
$6.02
Day's Low
$5.42
Volume
31,385
Avg. Vol
47,021
52-wk High
$38.68
52-wk Low
$5.42

Chart for

About

Menlo Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of serlopitant for the treatment of pruritus (itch) associated with dermatologic conditions, such as atopic dermatitis, psoriasis and prurigo nodularis. It is also evaluating the use of serlopitant for the... (more)

Overall

No Ratios Available.

Financials

  MNLO.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -- -- --
ROI: -- 0.21 14.27
ROE: -- 1.17 15.99

BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72

* MENLO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

BRIEF-Menlo Therapeutics Says Japanese Phase 2 Trial Of Serlopitant Halted

* MENLO THERAPEUTICS - CO'S PARTNERS FOR COMMERCIALIZATION OF SERLOPITANT IN JAPAN, INFORMED DECISION TO HALT JAPANESE PHASE 2 CLINICAL TRIAL OF SERLOPITANT

24 Apr 2018

Earnings vs. Estimates